Article
An engineered immunogen activates diverse HIV broadly neutralizing antibody precursors and promotes acquisition of improbable mutations.
Science translational medicine - 8 Jan 2025
Swanson Olivia M, Zhang Qianyi E, Van Itallie Elizabeth, Tian Ming, Brown Alecia R, Harris Caitlin, Kapingidza Anyway Brenda, Rhodes Brianna, Smith Lena M, Venkatayogi Sravani, Cronin Kenneth, Frazier McKenzie, Parks Rob, Bar Maggie, Jiang Chuancang, Martin Beem Joshua S, Cheng Hwei-Ling, Davis Jillian, McGovern Kelly, Newman Amanda, Edwards Robert J, Cain Derek, Alam S Munir, Wiehe Kevin, Saunders Kevin O, Acharya Priyamvada, Alt Fred, Haynes Barton F, Azoitei Mihai L
Abstract excerpt
Elicitation of HIV broadly neutralizing antibodies (bnAbs) by vaccination first requires the activation of diverse precursors, followed by successive boosts that guide these responses to enhanced breadth through the acquisition of somatic mutations. Because HIV bnAbs contain mutations in their B cell receptors (BCRs) that are rarely generated during conventional B cell maturation, HIV vaccine immunogens must...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
